Unprecedented Cure Rates of Hepatitis C Using Trio of Abbott Drugs

Full article at UPDATE 2-Abbott hepatitis C drugs bring high cure rates in trial Excerpt: "Nov 10 (Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very high cure rates for newly treated patients, Abbott said on Saturday." * 93 pct who failed prior drugs cured after 12 weeks * 97 pct of newly treated patients deemed cured after 12 weeks * One percent discontinue treatment due to side effects (Adds 100 pct cure rates with Gilead drug in small trial)